Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multiple-Dose, Placebo-Controlled, Multi-Center Study Comparing Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg to QVAR® 40 mcg (Beclomethasone Dipropionate HFA), Inhalation Aerosol in Treatment of Subjects With Asthma

NCT03562949 is registered in ClinicalTrials.gov with Amneal Ireland Limited as lead sponsor.

NCT NCT03562949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03562949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multiple-Dose, Placebo-Controlled, Multi-Center Study Comparing Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg to QVAR® 40 mcg (Beclomethasone Dipropionate HFA), Inhalation Aerosol in Treatment of Subjects With Asthma
Lead sponsor
Amneal Ireland Limited
Phase
Phase 3
Overall status
Terminated
Start date
December 6, 2018
Completion date
August 2, 2019
Enrollment
761 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

asthma